Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
26.80
+0.89 (3.43%)
Aug 10, 2026, 4:00 PM EDT - Market closed
Ultragenyx Pharmaceutical Market Cap
Ultragenyx Pharmaceutical has a market cap or net worth of $2.63 billion as of August 10, 2026. Its market cap has decreased by -0.75% in one year.
Market Cap
2.63B
Enterprise Value
3.40B
1-Year Change
-0.75%
Ranking
Category
Stock Price
$26.80
ChartMarket Cap Chart
Since January 31, 2014, Ultragenyx Pharmaceutical's market cap has increased from $1.19B to $2.63B, an increase of 121.56%. That is a compound annual growth rate of 6.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 2.63B | 18.71% |
| Dec 31, 2025 | 2.22B | -42.88% |
| Dec 31, 2024 | 3.88B | -1.06% |
| Dec 29, 2023 | 3.93B | 20.90% |
| Dec 30, 2022 | 3.25B | -43.33% |
| Dec 31, 2021 | 5.73B | -32.17% |
| Dec 31, 2020 | 8.45B | 242.48% |
| Dec 31, 2019 | 2.47B | 12.20% |
| Dec 31, 2018 | 2.20B | 11.33% |
| Dec 29, 2017 | 1.98B | -31.24% |
| Dec 30, 2016 | 2.87B | -34.05% |
| Dec 31, 2015 | 4.36B | 211.25% |
| Dec 31, 2014 | 1.40B | 17.73% |
| Jan 31, 2014 | 1.19B | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beam Therapeutics | 2.75B |
| AtaiBeckley | 2.68B |
| Viridian Therapeutics | 2.67B |
| Nurix Therapeutics | 2.65B |
| Trevi Therapeutics | 2.64B |
| Zai Lab | 2.62B |
| Precigen | 2.59B |
| Nektar Therapeutics | 2.58B |